- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Silicon Biosystems, S.p.A., a provider of specialized molecular and cell biology technology, today announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc.,to be headquartered in San Diego, California.
The newly formed business will focus on commercial operations and the development of the North American research and clinical diagnostics markets for the company's DEPArray™ technology platform.
"The formation of our own commercial operation in the U.S. represents a significant step forward for our business," stated Giuseppe Giorgini, CEO of Silicon Biosystems, S.p.A. "Our DEPArray™ platform will allow clinicians and researchers working to advance personalized medicine in areas such as clinical oncology to identify new biomarkers and improve patient treatment based on genetic information they have previously not had access to. We are excited to begin commercial discussions with thought leaders in the U.S."
The company's DEPArray™ technology exploits microelectronics and the principles of dielectrophoresis to isolate and manipulate cells in a suspension matrix. The approach, patented by Silicon Biosystems, offers the unique possibility of controlling individual cells and micro-particles inside a disposable cartridge. The DepArray™ platform makes it possible to find, sort, select and separate individual cells for further analysis or culturing.
About Silicon Biosystems
Silicon Biosystems, S.p.A. is based in Bologna Italy and has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems is one of the most innovative start-ups in the field of "lab-on-a-chip," based on active substrates, as testified by a number of awards and recognitions. The company is also an industrial member of the nano2Life EC Network of Excellence on nanobiotechnologies.
For more information, please click here
(619) 814-2370, x11
Copyright © Silicon BiosystemsIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Clues to inner atomic life from subtle light-emission shifts: Hyperfine structure of light absorption by short-lived cadmium atom isotopes reveals characteristics of the nucleus that matter for high precision detection methods July 3rd, 2015
Janusz Bryzek Joins MEMS Industry Group to Lead New TSensors Division - New Division will Focus on Accelerating Development of Emerging Ultra-high Volume Sensors Supporting Abundance, mHealth and IoT May 14th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015